For patients whose weight is tangled up with mood, medications, trauma, or eating patterns. PMHNP-led GLP-1 care across 14 states - because the mind and the metabolism were never separate.
Our integrated model is specifically designed for patients at the intersection of weight and mental health. It is not a cosmetic weight-loss service.
We offer both brand-name and compounded GLP-1 options depending on your insurance, budget, and clinical picture. All prescribing is done by Kristin McKnight, PMHNP-BC - not a telehealth mill.
Once-weekly subcutaneous injection. FDA-approved for chronic weight management (Wegovy) and type 2 diabetes (Ozempic). Covered by Medicare Part D and many commercial plans with prior authorization.
Dual GIP/GLP-1 agonist - once-weekly injection with superior weight loss data compared to semaglutide in head-to-head trials. FDA-approved for weight management (Zepbound) and diabetes (Mounjaro).
Available from PCAB-accredited compounding pharmacies when brand-name is unavailable or cost-prohibitive. Significantly lower cost than brand. Requires clinical discussion about regulatory status and quality sourcing.
Compounded option for patients who respond better to dual-agonist mechanism but cannot access brand-name. Available while shortage designations permit compounding under FDA regulations.
Daily oral tablet - an option for injection-averse patients. Lower bioavailability than injectable, but effective for patients who cannot or will not self-inject. Requires specific administration protocol (empty stomach, water only, 30-min wait).
We manage your GLP-1 alongside your existing psychiatric medications - monitoring for interactions, adjusting dosing if mood or appetite are affected, and tracking the psychological impact of weight change on your mental health.
Most GLP-1 providers track weight and labs. We also track PHQ-9 scores, eating disorder screen results, emotional eating patterns, binge urges, and the psychological experience of body change. Weight is never just a number here - it's part of your whole clinical picture.
This isn't a standard GLP-1 telehealth program with monthly check-ins. Every visit integrates weight, mood, eating behavior, and psychiatric medication as one picture.
Full psychiatric history, eating pattern assessment, validated screening tools (PHQ-9, GAD-7, EDE-Q), current medication review, and GLP-1 eligibility confirmation.
Medication selection (brand vs. compound, agent, starting dose) based on your clinical picture, budget, insurance, and psychiatric medication interactions.
Track weight, labs, mood scores, eating patterns, and psychiatric symptoms together. Titrate GLP-1 and adjust psychiatric medications as your body changes.
Psychotherapy available alongside medication management - addressing emotional eating, food-trauma connection, body image, and coping skill development as weight changes.